4//SEC Filing
Freeman Chris 4
Accession 0001871615-25-000010
CIK 0001576280other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 7:19 PM ET
Size
8.6 KB
Accession
0001871615-25-000010
Insider Transaction Report
Form 4
Freeman Chris
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-15+1,402→ 27,389 total - Tax Payment
Common Stock
2025-12-15$102.67/sh−594$60,986→ 26,795 total - Exercise/Conversion
Restricted Stock Units
2025-12-15−1,402→ 2,804 totalExercise: $0.00→ Common Stock (1,402 underlying)
Footnotes (3)
- [F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- [F2]This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- [F3]Not applicable for Restricted Stock Units.
Documents
Issuer
Guardant Health, Inc.
CIK 0001576280
Entity typeother
Related Parties
1- filerCIK 0001871615
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 7:19 PM ET
- Size
- 8.6 KB